ECM proteoglycans
REACTOME PATHWAYThe ECM proteoglycans pathway (Reactome ID: R-HSA-3000178) involves 7 genes and is affected by 32 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting ECM proteoglycans
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Tirofiban Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in | — | 299 |
| 2 | egcg | — | 300 |
| 3 | Resveratrol | — | 298 |
| 4 | Quercetin | — | 300 |
| 5 | Hesperidin | — | 300 |
| 6 | myricetin-3-O-galactopyranoside [Supplementary Concept] | — | 300 |
| 7 | Kaempferols | — | 300 |
| 8 | Methylene Blue | — | 200 |
| 9 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | — | 150 |
| 10 | (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole [Supplementary Concept] neutral analog of amyloid-binding thioflavin-T (BTA) that crosses | — | 300 |
| 11 | Apigenin 5,7,4'-trihydroxy-flavone, | — | 300 |
| 12 | caffeic acid | — | 300 |
| 13 | Vitamin | — | 295 |
| 14 | 2-Methoxyestradiol | — | 300 |
| 15 | arctigenin-4-O-(3''-O-acetyl-beta-D-glucoside) [Supplementary Concept] isolated from | — | 300 |
| 16 | Cladribine | — | 297 |
| 17 | Digitoxin | — | 300 |
| 18 | Digoxin | — | 299 |
| 19 | Disulfiram | — | 297 |
| 20 | Edetic Acid | — | 24 |
| 21 | Catechin | — | 300 |
| 22 | Vanillic Acid | — | 300 |
| 23 | Ouabain | — | 300 |
| 24 | Podophyllotoxin | — | 14 |
| 25 | Quinic Acid | — | 218 |
| 26 | Retinaldehyde | — | 300 |
| 27 | streptonigrin | — | 299 |
| 28 | Trifluridine | — | 295 |
| 29 | Hexachlorophene | — | 300 |
| 30 | Sorafenib | — | 300 |
| 31 | Crizotinib | — | 298 |
| 32 | scutellarein | — | 113 |
About the ECM proteoglycans Pathway
The ECM proteoglycans pathway is catalogued in Reactome (ID: R-HSA-3000178) and involves 7 genes. In the BiohacksAI corpus, 32 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include APP, ITGA2B, ITGAV, ITGB3, MUSK.